| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-05-07^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74c0f79ce52d35be0b6cea6dc47b0471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03437b23e659c0e8eeecc9a24cbc4dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9913327aea678f3df0a22cdcee9c6dfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a08a4b2bd07ed2701691df5d7d4e35f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4383ed53bc15a770159ae0aec55c34b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd9f9c0b7f03294cb9bb63e75c0e90d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db00823dcfe60c1a7cf805baaabab498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca51d8c4bf6c595d02b2e6922beeb55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca498cc5b86a7878ce26dd4061072da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_582e294f12393a99db18ba02e55a9633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4af9a1fed62050233af48d405840781c |
| publicationDate |
2010-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2155735-A2 |
| titleOfInvention |
Triazolyl aminopyrimidine compounds |
| abstract |
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer. |
| priorityDate |
2007-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |